Ashkon Software



MSLI - Merus Labs International Inc.

Merus Labs International Inc. logo Merus Labs International Inc. (MSLI) is a pharmaceutical company that focuses on acquiring, licensing, and marketing prescription drugs primarily in North America. The company is headquartered in Toronto, Canada and was founded in 2011.

Merus Labs acquires and markets drugs in a variety of therapeutic areas including men's health, urology, and cardiovascular diseases. Its products include Estrace cream, a product used for treating vulvar and vaginal atrophy in postmenopausal women; ELIGARD, a drug used for treating advanced prostate cancer; and Vancocin, a drug used for treating severe C. difficile-associated diarrhea. The company also provides drugs used in hospitals for treating various diseases and conditions.

In recent years, Merus Labs has made several acquisitions in order to expand its portfolio of products. In 2015, the company acquired a portfolio of products from ANIP Acquisition Company. In 2016, Merus Labs acquired a portfolio of established products from Novartis AG.

Merus Labs is listed on the Toronto Stock Exchange under the ticker symbol MSLI. In 2017, the company was acquired by Norgine B.V., a European pharmaceutical company, for approximately CAD 3




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer